195 related articles for article (PubMed ID: 32908869)
21. Peritumoral edema in meningiomas: pathophysiology, predictors, and principles for treatment.
Fiani B; Jarrah R; Bhandarkar AR; De Stefano F; Amare A; Aljameey UA; Reardon T
Clin Transl Oncol; 2023 Apr; 25(4):866-872. PubMed ID: 36427121
[TBL] [Abstract][Full Text] [Related]
22. Peritumoral brain edema in intracranial meningiomas.
Gurkanlar D; Er U; Sanli M; Ozkan M; Sekerci Z
J Clin Neurosci; 2005 Sep; 12(7):750-3. PubMed ID: 16165364
[TBL] [Abstract][Full Text] [Related]
23. BAG-1 expression in human meningioma and correlation with clinical characteristics.
Zhou K; Jin H; Zhou T; Luo Y
Med Oncol; 2013 Mar; 30(1):458. PubMed ID: 23322525
[TBL] [Abstract][Full Text] [Related]
24. The relationship between peritumoral brain edema and the expression of vascular endothelial growth factor and its receptors in intracranial meningiomas.
Otsuka S; Tamiya T; Ono Y; Michiue H; Kurozumi K; Daido S; Kambara H; Date I; Ohmoto T
J Neurooncol; 2004 Dec; 70(3):349-57. PubMed ID: 15662977
[TBL] [Abstract][Full Text] [Related]
25. Association between laminin γ1 expression and meningioma grade, recurrence, and progression-free survival.
Ke HL; Ke RH; Li B; Wang XH; Wang YN; Wang XQ
Acta Neurochir (Wien); 2013 Jan; 155(1):165-71. PubMed ID: 23053286
[TBL] [Abstract][Full Text] [Related]
26. Platelet-activating factor and edema surrounding meningiomas.
Hirashima Y; Hayashi N; Fukuda O; Ito H; Endo S; Takaku A
J Neurosurg; 1998 Feb; 88(2):304-7. PubMed ID: 9452240
[TBL] [Abstract][Full Text] [Related]
27. Peritumoral brain edema associated with meningioma: influence of vascular endothelial growth factor expression and vascular blood supply.
Yoshioka H; Hama S; Taniguchi E; Sugiyama K; Arita K; Kurisu K
Cancer; 1999 Feb; 85(4):936-44. PubMed ID: 10091773
[TBL] [Abstract][Full Text] [Related]
28. Microvascularization of Grade I meningiomas: effect on tumor volume, blood loss, and patient outcome.
Karsy M; Burnett B; Di Ieva A; Cusimano MD; Jensen RL
J Neurosurg; 2018 Mar; 128(3):657-666. PubMed ID: 28362240
[TBL] [Abstract][Full Text] [Related]
29. Peritumoral brain edema in meningiomas--influence of vascular supply on its development.
Inamura T; Nishio S; Takeshita I; Fujiwara S; Fukui M
Neurosurgery; 1992 Aug; 31(2):179-85. PubMed ID: 1513424
[TBL] [Abstract][Full Text] [Related]
30. Peritumoral Brain Edema and Surgical Outcome in Secretory Meningiomas: A Matched-Cohort Analysis.
Trivedi MM; Worley S; Raghavan A; Das P; Recinos PF; Barnett GH; Kshettry VR
World Neurosurg; 2021 Jan; 145():e170-e176. PubMed ID: 33022430
[TBL] [Abstract][Full Text] [Related]
31. p53 Protein expression in meningiomas - a clinicopathologic study of 55 patients.
Aguiar PH; Agner C; Simm R; Freitas AB; Tsanaclis AM; Plese P
Neurosurg Rev; 2002 Aug; 25(4):252-7. PubMed ID: 12172734
[TBL] [Abstract][Full Text] [Related]
32. Expression of vascular endothelial growth factor in human meningiomas and peritumoral brain areas.
Ding YS; Wang HD; Tang K; Hu ZG; Jin W; Yan W
Ann Clin Lab Sci; 2008; 38(4):344-51. PubMed ID: 18988927
[TBL] [Abstract][Full Text] [Related]
33. Influence of interleukin-6 on the development of peritumoral brain edema in meningiomas.
Park KJ; Kang SH; Chae YS; Yu MO; Cho TH; Suh JK; Lee HK; Chung YG
J Neurosurg; 2010 Jan; 112(1):73-80. PubMed ID: 19445568
[TBL] [Abstract][Full Text] [Related]
34. Impact of peritumoral brain edema on pre- and postoperative clinical conditions and on long-term outcomes in patients with intracranial meningiomas.
Ahmeti H; Caliebe A; Röcken C; Jansen O; Mehdorn MH; Synowitz M
Eur J Med Res; 2023 Jan; 28(1):40. PubMed ID: 36670509
[TBL] [Abstract][Full Text] [Related]
35. Lack of Correlation Between Immunohistochemical Expression of SPARC and Invasion in Different Grades of Meningiomas.
Rooprai HK; Martin AJ; King A; Appadu UD; Gullan RW; Thomas NWM; Pilkington GJ
Anticancer Res; 2020 Jun; 40(6):3081-3089. PubMed ID: 32487602
[TBL] [Abstract][Full Text] [Related]
36. Increased CD44 expression in primary meningioma: its clinical significance and association with peritumoral brain edema.
Sawaya R; Yamaguchi S; Ishi Y; Okamoto M; Echizenya S; Motegi H; Fujima N; Fujimura M
J Neurosurg; 2024 Feb; ():1-8. PubMed ID: 38335517
[TBL] [Abstract][Full Text] [Related]
37. An immunohistochemical study of HER2 expression in meningioma and its correlation with tumor grade.
Mahzouni P; Movahedipour M
Pathol Res Pract; 2012 Apr; 208(4):221-4. PubMed ID: 22420924
[TBL] [Abstract][Full Text] [Related]
38. Association between tumor size and peritumoral brain edema in patients with convexity and parasagittal meningiomas.
Shin C; Kim JM; Cheong JH; Ryu JI; Won YD; Ko Y; Han MH
PLoS One; 2021; 16(6):e0252945. PubMed ID: 34111188
[TBL] [Abstract][Full Text] [Related]
39. The Effect of Matrix Metalloproteinase-3 on the Prognosis and Biological Behaviour of Meningiomas.
Karaarslan N; Gurbuz MS; Caliskan T; Ayan E; Aker FV; Berkman MZ
Turk Neurosurg; 2016; 26(5):678-83. PubMed ID: 27438616
[TBL] [Abstract][Full Text] [Related]
40. Peritumoral brain edema in angiomatous supratentorial meningiomas: an investigation of the vascular endothelial growth factor A pathway.
Nassehi D; Sørensen LP; Dyrbye H; Thomsen C; Juhler M; Laursen H; Broholm H
APMIS; 2013 Nov; 121(11):1025-36. PubMed ID: 23398358
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
